Transmission and cost-effectiveness modelling to estimate the progress towards elimination and future strategy optimisation for gambiense human African trypanosomiasis in Uganda
Huang, C.-I.; Antillon, M.; Crump, R. E.; Sutherland, S. A.; Bessell, P. R.; Mugenyi, A.; Selby, R.; Brown, P. E.; Hooley, B.; Hope, A.; Dunkley, S.; Sunnucks, R.; Torr, S. J.; Tediosi, F.; Ndung'u, J.; Crowley, E. H.; Kidega, E.; Wamboga, C.; Rock, K. S.
Show abstract
BackgroundGambiense human African trypanosomiasis (gHAT) is a vector-borne disease with hundreds of thousands of people living at risk across Sub-Saharan Africa. Uganda, having reduced gHAT cases reported annually from 948 in 2000 to zero local cases since 2020, is a frontrunner to be verified by the World Health Organization (WHO) as having achieved elimination of transmission (EoT) of gHAT. It is now crucial to quantify the impact of the interventions deployed, quantify whether the last transmission event (LTE) and last case have already occurred, and determine the resources required to sustain the gains. MethodsWe employed a suite of mechanistic compartmental gHAT models, fitted to data from seven districts in Uganda that reported gHAT cases during 2000-2022, to address these questions. By combining and weighting the evidence from each model variant, we captured the uncertainty of achieving different elimination metrics across Uganda. Additionally, we utilised the dynamic transmission model outputs to perform a health economic analysis, identifying the most cost-effective strategies to avert disease burden. ResultsPredictions estimate that Uganda had the LTE in or before 2021 with high certainty (>95%). The model suggests that the local Ugandan case reported in 2019 may have been the last, but that there remains a 1.09% chance that cases could be reported after 2025. The cost-effectiveness analysis recommends that as transmission dynamics remain similarly low across all strategies, the Stop 2026 strategy, in which there is only passive screening from 2026 and subsequent reactive screening and vector control are only implemented if cases are detected, has the highest probability of being cost-effective and is predicted to have an economic cost of $139,913-249,031 between 2026-2040. ConclusionsTo sustain Ugandas success whilst ensuring efficient resource use, this modelling analysis recommends implementing the Stop 2026 strategy, which focuses on maintaining strong passive screening post-2026. This recommendation aligns with the current gHAT strategy in Uganda.
Matching journals
The top 5 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Modelling to infer the role of animals in gambiense human African trypanosomiasis transmission and elimination in DRC 97%
- A modelling assessment of short- and medium-term risks of programme interruptions for gambiense human African trypanosomiasis in the DRC 97%
- The effect of livestock density on Trypanosoma brucei gambiense and T. b. rhodesiense : a causal inference-based approach 96%
Similar papers in this journal
- The Role of Modelling and Analytics in South African COVID-19 Planning and Budgeting 95%
- Rural prioritization may increase the impact of COVID-19 vaccines in Sub-Saharan Africa due to ongoing internal migration: A modeling study 95%
- Assessing yellow fever outbreak potential and implications for vaccine strategy 95%
Similar papers in this journal
- Quantifying epidemiological drivers of gambiense human African Trypanosomiasis across the Democratic Republic of Congo 97%
- Bridging the gap: Using reservoir ecology and human serosurveys to estimate Lassa virus spillover in West Africa 95%
- A simulation-based method to inform serosurvey designs for estimating dengue force of infection using existing blood samples 95%
Similar papers in this journal
- The potential impact of Anopheles stephensi establishment on the transmission of Plasmodium falciparum in Ethiopia and prospective control measures 95%
- Quantifying the dynamics of COVID-19 burden and impact of interventions in Java, Indonesia 95%
- Estimating the cost-effectiveness of maternal vaccination and monoclonal antibodies for respiratory syncytial virus in Kenya and South Africa 94%
Similar papers in this journal
- What does the COVID-19 pandemic mean for the next decade of onchocerciasis control and elimination? 96%
- Predicting the impact of disruptions in lymphatic filariasis elimination programmes due to the outbreak of coronavirus disease (COVID-19) and possible mitigation strategies 96%
- Modelling the impact of COVID-19-related programme interruptions on visceral leishmaniasis in India 96%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.